The Cigna Group's revenue for the
three
months ended in Mar. 2026 was €59,073 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €237,940 Mil.
The Cigna Group's Revenue per Share for the
three
months ended in Mar. 2026 was €223.75.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €893.44.
During the past 12 months, the average Revenue per Share Growth Rate of The Cigna Group was 13.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 21.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 22.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, The Cigna Group's highest 3-Year average Revenue per Share Growth Rate was 75.80% per year. The lowest was -14.40% per year. And the median was 9.85% per year.
The Cigna Group (WBO:CIGN) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
The Cigna Group Revenue Related Terms
The Cigna Group Revenue Historical Data
* Premium members only.
The historical data trend for The Cigna Group's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, The Cigna Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group Revenue vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's Revenue distribution charts can be found below:
* The bar in red indicates where The Cigna Group's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €237,940 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cigna Group (WBO:CIGN) has a Revenue of €237,940 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on The Cigna Group and its competitors.
Is The Cigna Group's Revenue too high?
The Cigna Group's current Revenue is €237,940 Mil. Overall, The Cigna Group has a GF Score™ of 42/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Revenue compare to ELV and HUM?
The Cigna Group's Revenue of €237,940 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Plans company?
A good Revenue depends on the Healthcare Plans industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on The Cigna Group and its competitors. The Cigna Group's current Revenue is €237,940 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Significantly Undervalued. The stock's GF Value™ is €369.20, compared to a current price of €248.50 — trading 32.7% below its estimated fair value. The current Revenue is €237,940 Mil. The Cigna Group's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current Revenue is €237,940 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €248.50 is trading 32.7% below its estimated GF Value™ of €369.20.
GuruFocus considers The Cigna Group to be Significantly Undervalued.
Key valuation signals for WBO:CIGN:
Revenue: €237,940 Mil
GF Value™: €369.20 vs. price of €248.50 (32.7% below fair value)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
42GF Score
Get the complete analysis for WBO:CIGN
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
